Clinical experience with cyclosporine and azathioprine at Brigham and Women's Hospital.

Abstract

Cyclosporine (CsA) immunosuppressive therapy of renal allograft recipients at Brigham and Women's Hospital yielded a 20% increase in 12- and 24-month allograft survival over azathioprine (Aza) treated controls. A trend towards increased allograft survival with better HLA-A,B, or DR matching in recipients of cadaver allografts treated with CsA was… (More)

Topics

Cite this paper

@article{Milford1985ClinicalEW, title={Clinical experience with cyclosporine and azathioprine at Brigham and Women's Hospital.}, author={Edgar L. Milford and Robert Kirkman and Nicholas L. Tilney and Terry B. Strom and Charles B. Carpenter}, journal={American journal of kidney diseases : the official journal of the National Kidney Foundation}, year={1985}, volume={5 6}, pages={313-7} }